Fresenius Medical Care AG / DE0005785802

Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from September 15, 2025 to September 19, 2025 (each inclusive), 307,340 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
15 September 2025	58,000	42.3332	2,455,325.80	XETA
16 September 2025	119,745	42.4094	5,078,309.28	XETA
18 September 2025	30,000	43.3653	1,300,958.20	XETA
19 September 2025	99,595	43.3199	4,314,446.20	XETA

A total of 3,285,402 shares have been acquired within the framework of this share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.